Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Medartis Holding Temettü

Temettü kriter kontrolleri 0/6

Medartis Holding does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi0.6%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Hisse başına kazançCHF 0.30
Temettü verim tahmini0%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Aug 27
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

Aug 21
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

When Should You Buy Medartis Holding AG (VTX:MED)?

May 10
When Should You Buy Medartis Holding AG (VTX:MED)?

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Feb 14
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Oct 24
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Is Medartis Holding (VTX:MED) A Risky Investment?

Oct 03
Is Medartis Holding (VTX:MED) A Risky Investment?

Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 06
Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Jun 21
Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Jan 31
Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

Oct 30
Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

Sep 07
These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

When Should You Buy Medartis Holding AG (VTX:MED)?

Jul 29
When Should You Buy Medartis Holding AG (VTX:MED)?

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

May 06
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Feb 08
At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Jan 18
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Nov 10
We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Sep 29
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

Jun 08
Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

Mar 16
How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

We're Watching These Trends At Medartis Holding (VTX:MED)

Feb 09
We're Watching These Trends At Medartis Holding (VTX:MED)

Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

Jan 04
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Nov 19
What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if MED's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if MED's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Medartis Holding Piyasaya Karşı Temettü Getirisi
MED temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (MED)n/a
Pazarın Alt %25'i (CH)1.9%
Pazarın En İyi %25'i (CH)4.3%
Sektör Ortalaması (Medical Equipment)0.6%
Analist tahmini (MED) (3 yıla kadar)0%

Önemli Temettü: Unable to evaluate MED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate MED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate MED's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as MED has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin